![PRD_000970 PRD_000970](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000970.svg) | PRD_000970 | Name: | Synthetic peptide LR | Formula: | C43 H72 N13 O13 S | Definition date: | 2013-07-24 | Last modified: | 2013-07-24 |
|
![PRD_000926 PRD_000926](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000926.svg) | PRD_000926 | Name: | bicyclic peptide UK18-D-Ser, uPA inhibitor | Formula: | C78 H124 N27 O25 S3 | Definition date: | 2013-07-17 | Last modified: | 2013-07-17 |
|
![PRD_000927 PRD_000927](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000927.svg) | PRD_000927 | Name: | bicyclic peptide UK18-D-Aba inhibitor of uPA | Formula: | C79 H126 N27 O24 S3 | Definition date: | 2013-07-17 | Last modified: | 2013-07-17 |
|
![PRD_001127 PRD_001127](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001127.svg) | PRD_001127 | Name: | GRAMICIDIN A | Formula: | C103 H140 N20 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-10 | Last modified: | 2013-07-10 |
|
![PRD_001131 PRD_001131](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001131.svg) | PRD_001131 | Name: | GRAMICIDIN A | Formula: | C90 H133 N19 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
![PRD_001132 PRD_001132](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001132.svg) | PRD_001132 | Name: | CYCLOSPORIN D | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
![PRD_001128 PRD_001128](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001128.svg) | PRD_001128 | Name: | GRAMICIDIN C | Formula: | C101 H139 N19 O18 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-01 | Last modified: | 2013-07-01 |
|
![PRD_001129 PRD_001129](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001129.svg) | PRD_001129 | Name: | Microcin C7 analog | Formula: | C28 H51 N12 O11 S | Definition date: | 2013-07-01 | Last modified: | 2013-07-01 |
|
![PRD_000909 PRD_000909](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/CIX.svg) | PRD_000909 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide | Formula: | C25 H42 B N3 O6 | Definition date: | 2013-06-26 | Last modified: | 2013-06-26 |
|
![PRD_000935 PRD_000935](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000935.svg) | PRD_000935 | Name: | N-[(benzyloxy)carbonyl]-6-diazonio-5-oxo-L-norleucyl-L-valyl-L-prolyl-L-leucine | Formula: | C30 H43 N6 O8 | Definition date: | 2013-06-26 | Last modified: | 2023-11-03 |
|
![PRD_001126 PRD_001126](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001126.svg) | PRD_001126 | Name: | Microcin C7 ANALOG | Formula: | C28 H51 N12 O11 Se | Definition date: | 2013-06-26 | Last modified: | 2013-06-26 |
|
![PRD_001122 PRD_001122](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001122.svg) | PRD_001122 | Name: | CYCLOSPORIN D | Formula: | C64 H115 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 7 TO BE N-METHYL-L-ALANINE. | Definition date: | 2013-06-20 | Last modified: | 2013-06-20 |
|
![PRD_001123 PRD_001123](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001123.svg) | PRD_001123 | Name: | CYCLOSPORIN C | Formula: | C64 H114 N10 O14 | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). THIS IS A CYCLOSPORIN C VARIANT THAT DIFFERS AT 1, 3, AND 9 POSITIONS. | Definition date: | 2013-06-20 | Last modified: | 2013-06-20 |
|
![PRD_001102 PRD_001102](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001102.svg) | PRD_001102 | Name: | M48U12 | Formula: | C133 H217 N39 O31 S6 | Definition date: | 2013-06-19 | Last modified: | 2013-06-19 |
|
![PRD_001108 PRD_001108](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001108.svg) | PRD_001108 | Name: | CYCLOSPORIN A | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 8 TO BE 4,N-DIMETHYLNORLEUCINE. | Definition date: | 2013-06-19 | Last modified: | 2013-06-19 |
|
![PRD_000925 PRD_000925](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000925.svg) | PRD_000925 | Name: | Caspase inhibitor | Formula: | C42 H58 N6 O12 | Definition date: | 2013-06-12 | Last modified: | 2013-06-12 |
|
![PRD_001094 PRD_001094](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001094.svg) | PRD_001094 | Name: | CD4-MIMETIC MINIPROTEIN M48U1 | Formula: | C133 H216 N38 O32 S6 | Definition date: | 2013-06-12 | Last modified: | 2013-06-12 |
|
![PRD_001099 PRD_001099](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001099.svg) | PRD_001099 | Name: | CD4-MIMETIC MINIPROTEIN M48U7 | Formula: | C131 H214 N38 O33 S6 | Definition date: | 2013-06-12 | Last modified: | 2013-06-12 |
|
![PRD_001065 PRD_001065](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001065.svg) | PRD_001065 | Name: | teicoplanin | Formula: | C88 H97 Cl2 N9 O34 | Definition date: | 2013-05-29 | Last modified: | 2023-06-11 |
|
![PRD_002042 PRD_002042](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/4I4.svg) | PRD_002042 | Name: | (5R,6R,8S)-8-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-5-CYCLOHEXYL-6-HYDROXY-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE | Formula: | C20 H27 N6 O3 | Description: | P2- substituted N-acyl-prolylpyrrolidine inhibitor | Definition date: | 2013-05-29 | Last modified: | 2013-05-29 |
|
![PRD_002048 PRD_002048](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/X94.svg) | PRD_002048 | Name: | PERINDOPRILAT | Formula: | C17 H28 N2 O5 | Definition date: | 2013-05-29 | Last modified: | 2013-05-29 |
|
![PRD_002050 PRD_002050](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/X95.svg) | PRD_002050 | Name: | (S)-1-N2-(1-CARBOXY-3-PHENYLPROPYL)-L-LYSYL-L-TRYPTOPHAN | Formula: | C27 H34 N4 O5 | Description: | AnCE-Lisinopril-Tryptophan analogue | Definition date: | 2013-05-29 | Last modified: | 2013-05-29 |
|
![PRD_002070 PRD_002070](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/JKT.svg) | PRD_002070 | Name: | tert-butyl N-[[1-[(3S,5S)-5-[(2S)-2-[azanyl(oxidanyl)methyl]pyrrolidin-1-yl]carbonyl-1-(4-phenylbutanoyl)pyrrolidin-3-yl]-1,2,3-triazol-4-yl]methyl]carbamate | Formula: | C28 H41 N7 O5 | Description: | P2- substituted N-acyl-prolylpyrrolidine inhibitor | Definition date: | 2013-05-29 | Last modified: | 2013-05-29 |
|
![PRD_002071 PRD_002071](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/TDV.svg) | PRD_002071 | Name: | 1-[(2S,4S)-4-[4-(4-fluorophenyl)-1,2,3-triazol-1-yl]-2-pyrrolidin-1-ylcarbonyl-pyrrolidin-1-yl]-4-phenyl-butan-1-one | Formula: | C27 H30 F N5 O2 | Description: | P2-substituted N-acyl-prolylpyrrolidine inhibitor | Definition date: | 2013-05-29 | Last modified: | 2013-05-29 |
|
![PRD_002076 PRD_002076](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/X92.svg) | PRD_002076 | Name: | RAMIPRILAT | Formula: | C21 H28 N2 O5 | Definition date: | 2013-05-29 | Last modified: | 2013-05-29 |
|